Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.

TSXV:ARCH - Post by User

Arch Biopartners Inc

<< Previous

Bullboard Posts

Next >>

Post by Riverfolkon Jan 14, 2021 9:01pm

185 Views

Post# 32303366

International - Government Sponsored - Phase 2 trial

United States, California
VA San Diego Healthcare System	Recruiting
San Diego, California, United States, 92161
Contact: Steve Carter 858-552-8585 ext 2893 smcarter@vapop.uscd.edu
Principal Investigator: Mark Hepokoski, MD
United States, Florida
Broward Health Medical Center	Recruiting
Fort Lauderdale, Florida, United States, 33316
Contact: Laura Hudson 954-468-5237 lhudson@browardhealth.org
Principal Investigator: Sunil Kumar, MD
United States, Louisiana
LSU Health Shreveport	Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Kim Hutchinson 318-675-6682 Ksmit9@lsuhsc.edu
Principal Investigator: Steven Conrad, MD
Canada, Alberta
University of Calgary	Recruiting
Calgary, Alberta, Canada
Contact: Wilna Bouwer 403-614-9431 wilna.bouwer@ucalgary.ca
Principal Investigator: Alain Tremblay, MD
Turkey
Ankara City Hospital	Recruiting
Ankara, Turkey
Contact: rem Akn 0533 052 8862 irem.akin@monitorcro.net
Principal Investigator: H.Rahmet Gner, MD
Istanbul University Cerrahpasa	Recruiting
Istanbul, Turkey, 34098
Contact: Cansu iek 0531 260 6687 cansu.cicek@monitorcro.net
Principal Investigator: mer Fehmi Tabak, MD